University of Michigan
University of Michigan
Dexter, Michigan
David Frame is a clinical specialist in Hematology, Cell Therapy and Immuno-Hematology and assistant professor at the college of pharmacy at the University of Michigan. He has 30 years of experience in the oncology field. His current research focus is primarily related around the role of immune related therapies including CAR-T cell therapies where he is actively working on prevention of neurotoxicity as well as protocols to decrease the risk of relapse. He is also evaluating the roles of PD-1 inhibitor therapies in relapse after allogeneic transplant. One of the most challenging areas is his particpation of defining therapies of rare disorders seen in the Immuno-Hematology Clinic. Dr. Frame was very involved with helping to define some of the COVID treatment protocols and was a principle investigator on two clinical COVID trials developed at the University of Michigan. Having had a renal transplant himself he is very passionate about assuring adequate peventative therapy for COVID infection in immune compromised patients.
I do not have any relevant financial / non-financial relationships with any proprietary interests.
Thursday, April 28, 2022
9:10 AM – 9:45 AM
Thursday, April 28, 2022
9:45 AM – 9:55 AM
Thursday, August 11, 2022
9:10 AM – 9:45 AM
Thursday, August 11, 2022
9:45 AM – 9:55 AM
Thursday, November 17, 2022
9:10 AM – 9:45 AM
Thursday, November 17, 2022
9:45 AM – 9:55 AM